Position in AMGN
as of Jun 30, 2026
· filed Jul 27, 2026
Position Value
$354,515
-$156,019 QoQ
Shares Held
979
-32.5% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.32%
of 13F equity value
Holder Rank
#2,433
of 3,140 holders
Holding Since
Sep 2020
4 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in AMGN Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Providence First Trust Co holds $5,635,150 across 8 Drug Manufacturers - General names. AMGN ranks #7 (6.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
1,058 | $1,268,997 | |
| 2 | JNJ |
Johnson & Johnson
|
3,806 | $966,609 | |
| 3 | BIIB |
Biogen Inc.
|
4,175 | $902,050 | |
| 4 | MRK |
Merck & Co., Inc.
|
5,849 | $751,596 | |
| 5 | AZN |
Astrazeneca PLC
|
3,092 | $586,305 | |
| 6 | GILD |
Gilead Sciences, Inc.
|
3,775 | $476,933 | |
| 7 | AMGN |
Amgen Inc
This page
|
979 | $354,515 | |
| 8 | BMY |
Bristol Myers Squibb Co
|
5,695 | $328,145 |
All Filings in AMGN
Export CSV
4 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $354,515 | 979 | Shares | Sole | 2026-07-27 | |
| 2026-03-31 | $510,534 | 1,451 | Shares | Sole | 2026-05-05 | |
| 2025-12-31 | $518,786 | 1,585 | Shares | Sole | 2026-02-03 | |
| 2020-09-30 | $1,563,084 | 6,150 | Shares | Sole | 2020-11-13 | |
| No filing history on record for this holder in this stock. | ||||||